# XENPOZYME

NDC: 58468-0050
Generic name: olipudase alfa-rpcp
Labeler / Manufacturer: Genzyme Corporation
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: INTRAVENOUS
Marketing started: 20220829

FDA application: BLA761261

## Active ingredients

- OLIPUDASE ALFA: 20 mg/5.1mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"58468-0050"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=58468-0050
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=01a910ee-a33e-4be3-ac41-322d64c34311